Karen A. Kalita Sells 13,764 Shares of Cabot Co. (NYSE:CBT) Stock

Cabot Co. (NYSE:CBT) SVP Karen A. Kalita sold 13,764 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $101.73, for a total value of $1,400,211.72. Following the completion of the sale, the senior vice president now directly owns 34,312 shares of the company’s stock, valued at $3,490,559.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cabot Trading Up 0.1 %

Shares of Cabot stock opened at $102.23 on Wednesday. Cabot Co. has a 52-week low of $63.73 and a 52-week high of $103.46. The stock has a market cap of $5.65 billion, a PE ratio of 12.94, a PEG ratio of 1.05 and a beta of 1.27. The firm has a 50-day moving average of $92.83 and a 200-day moving average of $83.17. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.24.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, May 6th. The specialty chemicals company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.66 by $0.12. Cabot had a net margin of 11.51% and a return on equity of 26.21%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the previous year, the firm posted $1.33 EPS. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Cabot Co. will post 6.78 EPS for the current year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Friday, May 31st will be issued a $0.43 dividend. The ex-dividend date is Friday, May 31st. This is a boost from Cabot’s previous quarterly dividend of $0.40. This represents a $1.72 annualized dividend and a yield of 1.68%. Cabot’s payout ratio is currently 20.25%.

Institutional Trading of Cabot

A number of institutional investors have recently modified their holdings of CBT. EverSource Wealth Advisors LLC raised its stake in Cabot by 143.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 196 shares in the last quarter. Arlington Trust Co LLC acquired a new position in shares of Cabot in the 4th quarter valued at approximately $34,000. Hexagon Capital Partners LLC lifted its holdings in shares of Cabot by 81.8% during the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 207 shares during the period. SRS Capital Advisors Inc. boosted its position in shares of Cabot by 372.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock worth $42,000 after acquiring an additional 398 shares in the last quarter. Finally, GAMMA Investing LLC bought a new position in Cabot in the fourth quarter valued at approximately $44,000. 93.18% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CBT shares. UBS Group raised their price target on Cabot from $100.00 to $103.00 and gave the company a “neutral” rating in a report on Tuesday, May 7th. StockNews.com upgraded shares of Cabot from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating and lifted their target price for the stock from $88.00 to $95.00 in a report on Thursday, April 18th. Finally, Mizuho raised their price objective on shares of Cabot from $104.00 to $109.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. Three equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $93.67.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.